The record
Written from the 1 report below. Nothing here is unsourced.
- The Central Drugs Standard Control Organisation discovered one spurious drug and 220 drug samples failing quality standards during its August surveillance.
- Testing was conducted by central and state government laboratories across various distribution points.
- One spurious sample identified in Delhi was allegedly produced by an unauthorized manufacturer using a legitimate brand name.
- Regulatory authorities have initiated investigations into the spurious drug and are following procedures under the Drugs and Cosmetics Act.
What to watch next
- The outcome of the investigation into the spurious drug identified in Delhi.
- Further regulatory actions taken under the Drugs and Cosmetics Act.
- Monthly updates to the NSQ list on the CDSCO portal.
Coverage1
1 report
English national1
All filed from India
Named India · Delhi · Central Drugs Laboratories · Central Drugs Standard Control Organisation · Rajeev Singh Raghuvanshi · State Drugs Testing Laboratories
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.